# Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

> **NCT00002578** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 35 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cytarabine
- **DRUG:** gallium nitrate
- **DRUG:** leucovorin calcium
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT00002578
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-08
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2015-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002578, "Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*